禾元生物-U
(688765)
| 流通市值：25.79亿 | | | 总市值：199.20亿 |
| 流通股本：4628.00万 | | | 总股本：3.58亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 | 12,710,455.19 |
| 营业收入 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 | 12,710,455.19 |
| 二、营业总成本 | 50,498,085.64 | 226,004,752.39 | 152,128,298.94 | 104,059,673.66 |
| 营业成本 | 5,580,708.58 | 30,109,128.44 | 9,813,487.42 | 5,263,245.8 |
| 税金及附加 | 939,535.55 | 2,969,679.86 | 1,879,010.79 | 1,262,950.56 |
| 销售费用 | 1,694,732.17 | 8,696,542.92 | 4,847,569.76 | 2,695,026.46 |
| 管理费用 | 26,057,393.24 | 86,089,854.98 | 59,050,871.71 | 36,646,653.59 |
| 研发费用 | 16,098,856.04 | 92,660,591.42 | 72,533,776.31 | 55,936,535.09 |
| 财务费用 | 126,860.06 | 5,478,954.77 | 4,003,582.95 | 2,255,262.16 |
| 其中:利息费用 | 714,514.77 | 7,559,677.76 | 5,663,263.43 | 3,739,831.76 |
| 其中:利息收入 | 479,502.91 | 2,106,491 | 1,713,038.3 | 1,542,038.44 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 4,280,287.26 | 907,526.05 | - | - |
| 资产处置收益 | 508,870.1 | 3,788,302.22 | 3,189,411.24 | 2,463,090.15 |
| 资产减值损失(新) | -698,349.83 | -705,891.77 | -692,022.84 | -368,217.96 |
| 信用减值损失(新) | -11,760.95 | -84,041.01 | -38,621.66 | -354,937.62 |
| 其他收益 | 707,738.06 | 16,629,804.13 | 8,737,849.76 | 7,981,468.06 |
| 四、营业利润 | -36,083,196.19 | -157,607,699.54 | -121,270,904.18 | -81,627,815.84 |
| 加:营业外收入 | 37,264.24 | 570,351.71 | - | - |
| 五、利润总额 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 六、净利润 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 扣除非经常损益后的净利润 | -40,760,740.16 | -175,618,075.78 | -131,445,104.18 | -90,535,300.05 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.1 | -0.56 | -0.45 | -0.3 |
| (二)稀释每股收益 | -0.1 | -0.56 | -0.45 | -0.3 |
| 九、综合收益总额 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 归属于母公司股东的综合收益总额 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-24 | 2025-09-23 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |